FDA NDC Directory · JSON-LD · Markdown
NDC 61958-2501 · HUMAN PRESCRIPTION DRUG · TABLET
| Generic name | bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate |
|---|---|
| Labeler / Manufacturer | Gilead Sciences, Inc. |
| Marketing category | New Drug Application (innovator) · App NDA210251 |
| Dosage form / route | TABLET · ORAL |
| Active ingredients | BICTEGRAVIR SODIUM (50 mg/1) EMTRICITABINE (200 mg/1) TENOFOVIR ALAFENAMIDE FUMARATE (25 mg/1) |
| Marketing started | 20180207 |
| Package count | 4 |
Source: openFDA. Public-domain (CC0).